CRYSTAL PROTEINS OF BACILLUS THURINGIENSIS, GENES ENCODING THEM, AND HOSTS EXPRESSING THEM

Abstract: Two genes encoding the predominant polypeptides of Bacillus thuringiensis subsp. thompsoni cuboidal crystals were cloned in Escherichia coli and sequenced. The new class of crystal proteins have electrophoretic mobilities of 40 and 34 kilodaltons (kDa) with the deduced amino-acid sequences predicting molecular masses of 35,384 and 37,505 daltons, respectively. No statistically significant similarities were detected for the 40 kDa and 34 kDa crystal proteins to any other characterized Bacillus thuringiensis crystal protein or to each other. A 100 MDa plasmid encodes both crystal protein genes, which appear to be part of an operon with the 40 kDa gene 64 nucleotides upstream of the 34 kDa gene. Both crystal proteins are synthesized in approximately the same amounts. Even though small, compared to other crystal proteins, the 34 kDa crystal protein has insecticidal activity against lepidopteran larvae (Manduca sexta).

Description: CRYSTAL PROTEIN8 OF BACILLUS THURINGIENSIS, GENES ENCODIN THEM. AND HQ8T8 EXPRESSING THEM FIELD OF THE INVENTION The present invention is directed to two crystal proteins o Bacillus thuringiensis having insecticidal activity, the gene which encode them, and hosts expressing them. BACKGROUND OF THE INVENTION During sporulation, Bacillus thuringiensis (hereafter B.t.. produces proteinaceous crystals which are lethal to a variety o insect larvae. The proteins contained in the crystals, after bein ingested by susceptible insect larvae, are transformed int biologically active moieties by proteases present in the insec gut. The crystal proteins are highly potent at destroying th gut's epithelium, and even nanogram amounts are capable of killin susceptible larvae. Some of the major insect pests in agricultur and forestry are species of the order Lepidoptera. which are known to be susceptible to B.t. toxins. These crystal proteins have been grouped into four classes based on their host range and sequence homologies: Lepidoptera-specific (I) , Lepidoptera/Diptera-specific (II) , Coleoptera-specific (III) , and Diptera-specific (IV) (Hόfte, H. and H.P. hitely. 1989. "Insecticidal Crystal Proteins of Bacillus thuringiensis." Microbiol. Rev. 53:242-255). Significant amino-acid similarities exist between the crystal proteins of the different classes with the carboxy-terminal half of the crystal proteins containing most of the conserved sequences. Five well-defined regions are conserved among most of the known crystal proteins; these are located in the N-terminal half of the protein, which is responsible for toxicity (Hόfte, H. and H.P. hitely. 1989. "Insecticidal Crystal Proteins of Bacillus thuringiensis." Microbiol. Rev. 53:242-255). One exception is CytA, a 28 kDa cytolytic toxin from B. thuringiensis subsp. israelensis which has no detectable sequence identity with the other crystal proteins (Hόfte, H. and H.P. Whitely. 1989. "Insecticidal Crystal Proteins of Bacillus thuringiensis." Microbiol. Rev. 53:242-255). The majority of the crystal proteins and all " Class I lepidopteran-specific crystal proteins are synthesized as 130-140 kDa protoxins, which are then proteolytically cleaved in the insect idgut to 65-70 kDa active toxins. Some crystal proteins, Classes II and III, are produced as 65-70 kDa toxins. The only crystal protein which falls outside these two size ranges is CytA, one of five crystal proteins from dipteran-specific Bacillus thuringiensis subsp. israelensis. However, CytA has a different mode of action from other crystal proteins (Thomas, W.E., and D.J. Ellar. 1983. "Mechanism of action of Bacillus thuringiensis var. israelensis insecticidal 5-endotoxin." FEBS Lett. 154:362-367) and also has recently been reported to not be essential for mosquitocidal activity (Delecluse et al. 1991. "Deletion b in vivo recombination shows that the 28-kilodalton cytolytic polypeptide from Bacillus thuringiensis subsp. israelensis is not essential for mosquitocidal activity." J. Bacteriol. 173:3374-3381). SUMMARY OF THE INVENTION The present invention results from the identification of a unique crystalline insect toxin produced by B.t. subsp. thompsoni. The crystalline insect toxin comprises two unique polypeptides which are distinct from other B.t. proteins because of their size (elecrrophoretic mobilities of 40 kDa and 34 kDa) , and particularly, because their deduced amino-acid sequences do not contain any of the conserved regions observed in other characterized B.t. crystal proteins. The two genes encoding these unique polypeptides were cloned and expressed in E. coli. The 34 kDa polypeptide has insecticidal activity in the presence or absence of the 40 kDa polypeptide, and thus, may be used alone as an insecticide. While the 40 kDa protein appears to have no insecticidal activity against the tested lepidopteran species (M. sexta. A. rapae. H. virescens. and T. ni) , it may have a role in crystal formation because the naturally-occurring B.t. thompsoni crystals contain both proteins, and thus, may be used in combination with the 34 kDa protein as an insecticide. Because of the relatively small length of the genes encoding these polypeptides, achieving their expression in plants should be easier than achieving expression of the other types of B.t. toxins. Additionally, the construction and expression of chimaeric B.t. toxins will be facilitated by the small size of these genes. Chimaeric toxins can be used to expand the host range of a specific toxin and decrease the lik-slihood that insect resistance will develop. BRIEF DESCRIPTION OF THE FIGURES Figure 1: Electron micrographs of crystals from B.t. thompsoni. (A) Thin-section of a sporulating B.t. thompsoni cell containing a crystalline inclusion. (B) Three-dimensional view of a B.t. thompsoni crystal. The bar in each panel represents lOOnm. Figure 2: Electrophoretic analysis of crystals and inclusions from recombinant E. coli clones. (A) Coomassie-blue stained gel of purified B.t. thompsoni crystals (lane 1) and purified inclusions from E. coli clone pKB102 (lane 2) . (B) I munoblot with antibody specific for the 40kDa crystal protein (lane 1, B.t. thompsoni crystals; lanes 2-7, purified E. coli inclusions: lane 2, pKB102; lane 3, pKB107; lane 4, pKB109; lane 5, pKB200; lane 6, pKB201; lane 7, pKB202. (C) Immunoblot with antibody specific for the 34kDa crystal protein (lane designations are the same as in panel B) . The E. coli DH5α was the host for the plasmids pKB102 and pKB109, while E. coli JGM was the host for pKB107 and E. coli JM103 was the host for pKB200, pKB201, and pKB202. Figure 3: Restriction maps showing the location of the crystal protein genes on the recombinant plasmids used in this study. The positions and orientations of the two crystal protein genes are indicated by arrows. The open area in pKB107 is a deleted region. The black triangle in pKB109 is the site of gd insertion. The diagramed size of pKB109 does not account for the additional 5.7 kb of gd DNA. The following abbreviations were used for restriction sites: A, Apal; B, BstEII; C, Cial; E, EcoRI; H, Hindlll; M, Smal; N, Nrul; Ns, Nsil; S, SstI; Sa, Sail; X, Xbal. The restriction sites shown on pKB200 and pKB201 were obtained from PCR-amplification. The SstI site in parentheses on pKB202 was lost during cloning. Figure 4: Nucleotide and deduced amino-acid sequences of the 40kDa and 3 kDa crystal protein genes. Ribosome-binding sites are underlined twice and the inverted repeats which form a potential transcription terminator are marked by long arrows under the sequence. Figure 5: Electrophoretic analysis of plasmids and location of crystal protein genes in B.t. thompsoni. Lanes 1 and 2: agarose gel stained with ethidium bromide of plasmids isolated from HD-1-Dipel (lane 1) and B.t. thompsoni (lane 2) . The numbers on the left indicate size in MDa. Lane 3: autoradiograph of lane 2 DNA transferred to nitrocellulose and hybridized with a 32P-labelled fragment from the region encoding the B.t. thompsoni crystal protein genes. The black dot to the right of lane 2 indicates the plasmid carrying the crystal protein genes. Some hybridization was observed with the linearized fragments, which most likely resulted from shearing of the crystal protein gene-containing plasmid. DETAILED DESCRIPTION OF THE INVENTION In one embodiment, the present invention is a unique crystalline insect toxin produced by B.t. , comprising two polypeptides having electrophoretic mobilities of about 34 kDa and 40 kDa. In particular, the present invention is directed to the two crystal polypeptides of B.t. subspecies thompsoni having electrophoretic mobilities of around 34 kDa and 40 kDa. As mentioned above, the 34 kDa protein may be used alone as an insecticide or in combination with the 40 kDa protein. Another embodiment of the present invention is the two genes encoding these proteins. Also, the present invention is directed to probes used to isolate the genes. Still another embodiment is a recombinant DNA expression vector containing one or both of the genes encoding the two proteins. In addition, the present invention includes hosts transformed by a recombinant DNA expression vector containing one or both genes. Finally, the present invention is directed to a process for producing the novel proteins using a host transformed with a recombinant DNA expression vector containing the genes. It is known that conservative substitutions of amino acids in proteins can be made without significantly affecting biological activity, resulting in a homologous sequence which retains its insecticidal activity. For example, structurally related amino acids (such as Asp and Glu) may be substituted for each other. The insecticidal activity of such homologous sequences may be readily determined using the routine insect toxicity assay described in Example l below. Further, as a result of the degeneracy of the genetic code, it is possible to generate a variety of nucleotide sequences through mutagenic or DNA- synthesizing techniques which are capable of encoding the same amino acid seouence. Such obvious modifications to the proteins and their underlying DNA sequences are considered to be within th scope of the present invention. Suitable host cells include prokaryotes and eukaryotes. Preferred prokaryotes, both Gram-negative and -positive, include Enterobacteriaceae. such as Escherichia. Erwinia. Shigella, Salmonella, and Proteus; Baciliaceae; Rhizobiaceae. such as Rhizobiu ; Spirillaceae. such as photobacterium, Cvanobacteria. Zvmomonas, Serratia, Aeromonas. Vibrio. Desulfovibrio. Sp * iτ-i11-ι-ιτn: Lactobacillaceae; Pseudo onadaceae. such as Pseudomonas and Acetobacter; Azotobacteraceae and Nitrobacteraceae. Suitable eukaryotes include fungi such as Phycomycetes and Ascomycetes, which include yeast, such as Saccharomyces and Schizosaccharo yces; and Basidiomycetes yeast, such as Rhodotorula. Aureobasidium. Sporobolomvces. and the like. Two particularly preferred hosts are E. coli DH5α and JM103. Suitable expression vectors include those which are functional in a selected host. Examples of such vectors are pBR322, pACYC184, PPL703E, RSF1010, pR01614, pBluescript II SK+/~, pBluescript II KS+/-, and pKK223-3. Of those, pKK223-3 is a preferred expression vector. The expression vector may include any of various transcriptional regulatory regions, such as regions of the trp gene, lac gene, gal gene, the lambda left and right promoters, the Tac promoter, or the naturally-occurring promoters associated with the two genes. The present invention is described more fully by the example below, although it is in no way limited to this particular example. EXAMPLE 1 B.t. thompsoni was obtained from P. Baumann, university of California, Davis (originally from H. D. Burges with the Dulmage designation HD-542) . B.t. kurstaki HD-1 Dipel was obtained from L. A. Bulla (Kronstad et al. 1983. "Diversity of locations for Bacillus thuringiensis crystal protein genes." J. Bacteriol. 154:419-428) . E. coli DH5α (Bethesda Research Laboratories) and JM103 were the hosts for cloning purposes. E. coli DPWC and JGM (obtained from Melvin Simon via Kelly Hughes) were used for yδ mobilization. Plasmids pTZ18R (Pharmacia) and pBluescript II KS+ (Stratagene) were used as cloning vectors. Plasmid pKK223-3 (Pharmacia) was used as an expression vector for the crystal protein genes. Molecular methods and enzymes The standard molecular methods used have been described previously (Sambrook et al. 1989. "Molecular cloning: a laboratory manual," 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) . B.t. thompsoni plasmid DNA was isolated as described previously (Kronstad et al. 1983. "Diversity of locations for Bacillus thuringiensis crystal protein genes." J. Bacteriol. 154:419-428) and purified by CsCl gradient centrifugation. E. coli plasmid DNA was isolated by the method of Birnboi and Doly (1979. "A rapid alkaline extraction procedure for screening recombinant plasmid DNA." Nucleic Acids Res. 7:1513-1523). E. coli transformation was by electroporation (Dower et al. 1988. "High efficiency transformation of E. coli by high voltage electroporation." Nucleic Acids Res. 16:6127-6145) or with competent cells (Sambrook et al. 1989. "Molecular cloning: a laboratory manual," 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) . Restriction enzymes were purchased from New England BioLabs, Inc., Boehringer-Mannhei , and Bethesda Research Laboratories. Calf intestinal alkaline phosphatase came from Boehringer-Mannheim. Klenow fragment, exonuclease III and reverse transcriptase were purchased from Bethesda Research Laboratories. All enzymes were used according to the instructions of the manufacturers. Electron microscopy A synchronized culture of B.t. thompsoni was grown at 30*C until the presence of phase-dark prespores and the formation of crystalline inclusions were observed by phase-contrast microscopy. The cells were harvested by centrifugation and resuspended in 0.1 M cacodylate buffer, pH 7.3. The cells were fixed with 3% glutaraldehyde and resuspended in 1.5% Noble agar. The agar-embedded cells were washed in cacodylate buffer and dehydrated with ethanol. Finally, the cells were washed with propylene oxide and infiltrated and embedded in plastic resin. After thin-sectioning, the samples were viewed by scanning electron microscopy. Purified B.t. thompsoni crystals were prepared as above, but viewed by transmission electron microscopy. B.t. thompsoni plasmid DNA hybridization Plasmids were isolated from B.t. thompsoni and B.t. kurstaki HD-1 Dipel, separated in a 0.6% horizontal agarose gel and transferred to nitrocellulose as described previously (Kronstad et al. 1983. "Diversity of locations for Bacillus thuringiensis crystal protein genes." J. Bacteriol. 154:419-428) . A DNA fragment specific to the 40 kDa and 34 kDa genes was radiolabelled by hexanucleotide random priming (Feinberg et al. 1983. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity." Anal. Biochem. 132:6-13). The radiolabelled DNA was subjected to alkaline denaturation and allowed to hybridize to the Southern blot DNA in 20% formamide, 3X SSC (IX SSC is 0.15 M NaCl plus 0.015 M sodium citrate) for 20 h at 25°C. The blot was washed in 2X SSC, 0.1% sodium dodecyl sulfate (SDS) for 15 min at 25°, 37°, and 42°C, air-dried and exposed to Kodak XAR film. Antibody production and N-terminal sequencing Crystals were isolated from B.t. thompsoni and purified by Renografin gradient centrifugation. The purified crystals were solubilized in 4% SDS/10% b-mercaptoethanol and electrophoresed in a preparative 10% SDS-polyacrylamide gel. The peptide bands were visualized by staining in 0.15 M potassium chloride and the individual protein bands were excised from the gel. The proteins were eluted from the polyacrylamide gel slices at 4°C with 4 Watts constant power for 3 h by using the ISCO electroelution- concentration device. The protein concentration of the samples was determined by the method of Bradford (1976. "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding." Anal. Biochem. 72:248-254). Each sample, containing 20 μg of protein in 0.5 ml 10 mM Tris/1 mM EDTA, was emulsified 1:1 with Freund's Complete adjuvant and injected into mice subcutaneously (Herbert, W. J. 1968. "The mode of action of mineral-oil emulsion adjuvants on antibody production in mice." Immun. 14:301-318). Five weeks later a booster of 10 ng of each sample was administered intramuscularly and ascites sarcoma 180/TG cells were injected into the mice intraperitoneally. The polyclonal antiserum was harvested from the ascites fluid 10-14 days later and was centrifuged to obtain a clarified supernatant and used without further purification. B.t. thompsoni crystals were purified and electrophoresed as above and transferred to an Immobilon membrane (Millipore) . The N-terminal amino-acid sequences of the 40 kDa and 34 kDa crystal proteins were determined by automated Edman degradation. Crystal protein gene cloning Based on the amino-acid sequences, two degenerate DNA oligonucleotides were synthesized: a 38-mer for the 40 kDa crystal protein, 5 » -ATG AA(C,T) TTC AAC AA(C,T) AT(C,T) ACI GGI AAC TT(C,T) AAG GAG GT-3', and a 32-mer for the 34 kDa crystal protein, 5'- ATG AAT GA(C,T) AT(T,A) GCI CA(G,A) GAT GCI GCI (C,A)GI GC-3• . Deoxyinosine was used as a neutral base at the fourfold redundant positions to reduce base mismatching. B.t. thompsoni plasmid DNA was digested with EcoRI and subjected to sucrose gradient centrifugation. Fractions were separated by agarose gel electrophoresis, transferred to nitrocellulose and hybridized to both oligonucleotides. Probe-reactive fractions were ligated into pTZ18R (which had been digested with EcoRI and treated with calf intestinal alkaline phosphatase) , and transformed into E. coli DH5α. Positive clones were selected by colony blot hybridization with the 38-mer and 32-mer oligonucleotides and by the production of proteins reacting with the 40 kDa and 34 kDa antibodies. Two clones were selected, both of which contained the same 8.4-kb fragment but in opposite orientations, as indicated by restriction enzyme mapping (data not shown) . One of the clones, pKBlOO, was subcloned by removing an Sstl-SstI fragment from the 5'-end and ligating the 7.5-kb SstI-EcoRI fragment into pTZ18R, generating pKB102. Subclone Construction Recombinant plasmid pKB102 was used to generate the subclones pKB107 and pKB109. pKB102 was digested with BstEII followed by digestion with exonuclease III and treatment with SI nuclease to generate blunt ends that were ligated to yield pKB107. To generate pKB109, the transposon 6 was mobilized by bacterial mating into an Sstl-Nrul subclone of pKB102 (see Fig. 3) . To obtain specific clones of the genes encoding the 40 kDa and 34 kDa crystal proteins, the polymerase chain reaction (PCR) was used to isolate their respective sequences. The priming oligonucleotides were used to amplify the 40 kDa coding region (with the introduction of an Apal site upstream and a Sail site downstream) and also the 34 kDa coding region (with the introduction of a Smal site upstream and a Xbal site downstream) . The sequences of the PCR primers were as follows: for the gene encoding the 40 kDa protein, sense strand 5'-GAG GGC CCA ATA AGG TGT CAG CT-3 ' and its nonsense strand 5' -GCG TCG ACT ATC ATT CCA TTA CAC-3 ' ; for the gene encoding the 34 kDa protein, sense strand 5'-CTC CCG GGT GTA ATG GAA TGA TA-3 ' and its nonsense strand 5'-GCT CTA GAT CTT CAC AAT CCG GA-3 ' . Amplification was performed in 100 μl reaction volume containing 5 ng template, 1 μg of each primer, 200 μM dNTP's, 2.5 U Tag DNA Polymerase (Promega) and Tag buffer. The thirty-two rounds of amplification consisted of 15s at 94"C, 15s at 45"C, and 60s at 72°C in a Coy thermal cycler. The PCR-generated fragments were digested with the appropriate restriction enzymes and cloned into pBluescript II KS+ to generate pKB401 (40 kDa) and pKB341 (34 kDa) . Expression vectors were then constructed by excising the 40 kDa and 34 kDa genes (as a 997-bp fragment Kpnl(blunt)-Hindlll fragment and a 1300-bp PstI-SstI(blunt) fragment, respectively) from these plasmids and ligating them into pKK223-3, generating pKB200 and pKB201. To generate a subclone containing both crystal protein genes, the 40 kDa gene was excised from pKB200 as a EcoRI-Hindlll(blunt) fragment and ligated into pKB201 digested with EcoRI-PstI(blunt) generating, pKB202. DNA Seguencing Both strands of the DNA were sequenced using the dideoxy-chain termination method of Sanger et al. (1977. "DNA Seguencing with chain-terminating inhibitors." Proc. Natl. Acad. Sci. USA. 74:5463- 5467) . DNA fragments from pKB102 were subcloned into pTZ18R and successive unidirectional deletions were created using exonuclease III. The second strand and any gaps in the first strand were sequenced using a series of complementary synthetic oligonucleotides. Sequencing templates were generated by subjecting CsCl-purified plasmid DNA to alkaline denaturation followed by ethanol precipitation. Sequencing was accomplished using [o.- 35 S]dATP (New England Nuclear) and the Sequenase Version 2.0 kit (US Biochemical) . Sequence similarities were analyzed with FASTDB from the IntelliGenetics software package. The sequence data disclosed herein has been assigned the accession number in GenBank of M76442. Insect toxicity assays Toxicity of purified B.t. thompsoni crystals and E. coli inclusions to neonate larvae of the tobacco hornworm, Manduca sexta. was tested as described previously except that the crystals and/or inclusions were not solubilized prior to the assay (Schnepf et al. 1990. "Specificity-determining regions of a lepidopteran- specific insecticidal protein produced by Bacillus thuringiensis." J. Biol. Chem. 265:20923-20930). Protein concentrations were estimated by densito etry (202 Ultrascan laser densito eter; LKB Instruments, Inc.) of Coomassie-blue stained SDS-polyacylamide gels with dilutions of bovine globulin used as standards. Crystal structure To determine the shape of B.t. thompsoni crystals, cells were grown until phase-dark prespores and crystals were observed. The electron micrograph of a thin-sectioned cell (Fig. IA) showed the production by B.t. thompsoni of a square crystal alongside the spore. To determine whether the crystals were flat or cuboidal, purified B.t. thompsoni crystals were viewed by transmission electron microscopy. The electron micrograph in Fig. IB showed the three-dimensional structure of a B.t. thompsoni crystal as cuboidal rather than flat. Cloning of the B.t. thompsoni genes in E. coli Electrophoretic analysis of purified B.t. thompsoni crystals showed only two peptide bands which migrated at estimated electrophoretic mobilities of 40,000 and 34,000 daltons (Fig. 2A, lane 1) . Immunoblots showed the specificity of the two crystal protein antibody preparations (Fig. 2B and 2C, lane 1) . Additionally, these two antibodies did not cross-react with representative members from each of the four crystal protein classes or with CytA (data not shown) . To facilitate cloning of the B.t. thompsoni crystal proteins, the N-terminal sequence was determined for the 40 kDa polypeptide, MNFNNITGNFKDVTELFTDYANQX(S)XQNG, and the 34 kDa polypeptide AIMNDIAQDAARAXDIIAGPFIRPGT(T)PXN(N)QLF(N) (Y)X(I) (G) (N) . Residues in parentheses are uncertain and unknown residues are represented with an X. From these amino-acid sequences, DNA oligonucleotides were synthesized. Both oligonucleotides hybridized to a 7.5-kb Sstl-EcoRI fragment cloned from B.t. thompsoni plasmid DNA as described above. Recombinant E. coli carrying pKB102 (Fig. 3), synthesized two polypeptides which reacted with the 40 kDa and 34 kDa antibodies, respectively (Fig. 2B and C, lane 2) . The mobilities of the polypeptides produced from pKB102 were identical or very similar to those polypeptides present in preparations of purified B.t. thompsoni crystals (Fig. 2A, lanes 1 and 2) . A ca. 100 kDa peptide was visible in immunoblots of B.t. thompsoni and pKB102 which cross-reacted with both antibody preparations (Fig. 2B and C, lanes 1 and 2) . This peptide species is possibly an aggregate of the 40 kDa and 34 kDa crystal proteins, or might represent another polypeptide present on the DNA cloned in pKB102 which cross-reacts with both antibody preparations. Seguence determination of the cloned crystal protein genes The region of pKB102 containing the genes encoding the 40 kDa and 34 kDa crystal proteins was sequenced (Fig. 3) . The DNA sequence (Fig. 4) revealed the presence of two open reading frames in the same orientation and separated by 64 nucleotides, with each open reading frame preceded by a potential ribosome-binding site. The sequence of the first open reading frame matched the N-terminal amino-acid sequence of the 40 kDa protein determined previously, and could encode a polypeptide with a predicted molecular mass of 35,384 daltons. The N-terminal amino-acid sequence predicted from the sequence of the second open reading frame corresponded to the N-terminal amino-acid sequence of the 34 kDa protein. This ORF could code for a polypeptide with a predicted molecular mass of 37,505 daltons. Since both strands of the DNA were sequenced, the discrepancies between the predicted molecular masses of the two crystal proteins and those estimated by electrophoretic mobility most likely resulted from anomalous migration during electrophoresis. Molecular mass discrepancies have also been observed for CryllA and Cr IIB: each sequence predicts a size of ca. 71 kDa, but the proteins migrate as 65 kDa and 50 kDa, respectively. The sequences were searched for any regions that resembled B. thuringiensis. Bacillus subtilis or E. coli promoter structures. No likely promoter sequences were found in the sequenced region, either in the region between the two genes or for approximately 700 nucleotides upstream of the 40 kDa crystal protein gene. The sequenced region was searched for the presence of inverted repeat structures which could result in transcription termination. A sequence which could serve as a Rho-independent transcriptional terminator was found downstream of the 34 kDa gene. Transcription of this region could lead to the formation of a stem-and-loop structure with a ΔG° of -19.1 kcal, calculated according to the rules of Tinoco (1973. "Improved estimation of secondary structure in ribonucleic acids." Nature. (London) New Biol. 246:40-41). However, this inverted repeat structure does not have the classical GC-rich region of other terminators or a run of T's after the stem-and-loop, thus this structure may not serve to terminate transcription. The organization of the two ORFs, the presence of individual ribosome-binding sites, the lack of a promoter between the two genes, and the putative transcription terminator suggest that these genes are likely to be part of an operon. This operon may have additional ORFs upstream of the 40 kDa crystal protein gene and possibly downstream of the 34 kDa crystal protein gene as well. The predicted amino-acid sequences of the two ORFs were analyzed to identify any similarities to other /mown protein sequences. No statistically significant similarities were detected for the 40 kDa or 34 kDa crystal proteins to any protein sequence, including any other sequenced crystal protein. Additionally, comparison of the 40 kDa and 34 kDa amino-acid sequences showed no substantial regions of identity between the two proteins. Plasmid profile To examine the plasmid profile of B.t. thompsoni, purified plasmids were separated in an agarose gel. The sizes of the B.t. thompsoni plasmids were determined by comparison with sized plasmids isolated from B. thuringiensis HD-1-Dipel (Fig. 5, lanes 1 and 2) . Five plasmids were observed in B.t. thompsoni ranging from 40 MDa to greater than 150 MDa with four of the plasmids clustered around 100 to 150 MDa (Fig. 5A, lane 2) . To determine which plasmid encoded the crystal protein genes, B.t. thompsoni plasmid DNA was transferred to nitrocellulose and hybridized with a radioactive probe specific to the 40 kDa and 34 kDa genes. The crystal protein genes were located on the predominant plasmid species of -100 MDa (Fig. 5, lane 3) . This observation agrees with the results of Carlton and Gonzalez (1984. "Plasmid-associated delta-endotoxin production in Bacillus thuringiensis," pages 387-400. In A. T. Ganesan and J. A. Hoch (eds.), Genetics and biotechnology of bacilli. Academic Press, New York) , who showed that an acrystalliferous strain of B.t. thompsoni resulted from the loss of a 100 MDa plasmid. Description of subclone constructions As described above, subclones of pKB102 were generated in which the gene expression of each crystal protein was individually eliminated. Insertional inactivation or deletion were used, in order to leave any regulatory elements on pKB102 intact. Because of the lack of unique restriction enzyme sites within the 40 kDa gene, ηδ transposition was used to inactivate the expression of its gene product. Plasmid pKB109 (Fig. 3) had a ηδ insertion in the 40 kDa crystal protein gene after nucleotide 161 of Fig. 4 , resulting in the synthesis of only the 34 kDa gene product (Fig. 2B and C, lane 4). Though part of an operon, the 34 kDa crystal protein gene was expressed in pKB109, either because -y δ does not contain any transcriptional terminators or it contains a promoter which was used for transcription of the 34 kDa gene. A different approach was used to inactivate the 34 kDa crystal protein gene; a unique restriction enzyme site, BstEII, within the 34 kDa gene was used to initiate exonuclease III digestion. A resulting subclone, pKB107 (Fig. 3), had a deletion in the 34 kDa crystal protein gene from nucleotides 1190 to 1920 of Fig. 4. This clone expressed only the 40 kDa crystal protein as demonstrated by immunoblot analysis (Fig. 2B and C, lane 3). To determine the insecticidal activity of the crystal proteins, subclones were constructed that contained only the 40 kDa gene (pKB200) , only the 34 kDa gene (pKB201) , or both genes ( pKB202) (Fig. 3). In these subclones, the genes were expressed under the control of the strong tac promoter. Each gene had its own Shine-Dalgarno sequence present and was cloned upstream of the E. coli rrnB Tl and T2 terminators to insure transcriptional termination. Recombinant Σ. coli with pKB200 expressed only the 40 kDa crystal protein (Fig. 2B and C, lane 5) , whereas the subclone pKB201 synthesized only the 34 kDa crystal protein (Fig. 2B and C, lane 6) . Both crystal proteins were expressed in E. coli carrying pKB202 (Fig. 2B and C, lane 7) . Insect toxicity assays Purified B.t. thompsoni crystals and inclusions isolated from several recombinant E. coli clones were tested for toxicity to the larvae of the lepidopteran, Manduca sexta. The samples were not solubilized prior to testing for toxicity to insect larvae, because the various methods (pH >11 or 0.2% sarkosyl in 0.1 M carbonate buffer) which were successful in solubilizing the crystals or inclusions destroyed their biological activity (data not shown) . Solutions that normally solubilize other crystal proteins and inclusions (i.e. 0.1 M carbonate buffer, pH 10, 0.2 % b-mercaptoethanol) resulted in concentrations of soluble protein that were too low to use in the insect assays. The recombinant E. coli carrying pKB102, which produced both crystal proteins, exhibited equivalent toxicity levels as the B.t. thompsoni crystals with 50% killing observed at 0.40 μg/cm2 (see Table 1 below) . The clone, pKB202 (which has been deposited with the American Type Culture Collection at 12301 Parklawn Drive, Rockville, Maryland, USA and given the deposit number ATCC 68889) , had an LC50 value of 0.98 μg/cm2, however, the 34 kDa polypeptide concentration was the same as B.t. thompsoni and pKB102 of 0.25 ug/cι-12. When only the 34 kDa crystal protein was expressed, in E ^ coli carrying pKB109 (which has also been deposited with the American Type Culture Collection and given the deposit number ATCC 68891) and pKB201 (the former of which has been deposited with the American Type Culture Collection and given the deposit number ATCC 68890) , the concentration of 34 kDa polypeptide at the LC50 levels were similar, 0.25 μg/cm2, to those observed in clones expressing both crystal proteins, pKB102 (which has been deposited with the American Type Culture Collection and given the deposit number ATCC 68892) and pKB202 (Table 1) . * However, the E. coli that expressed only the 40 kDa crystal protein, clones carrying pKB107 and pKB200, were not toxic to the larvae at concentrations of 3 μg/cm 2 (Table 1) . B.t. thompsoni crystals also demonstrated toxicity against the lepidopteran, Artogeia rapae (Cabbage white) , but did not kill larvae of Heliothis virescens or Trichoplusia ni at concentrations of 3 μg/cm 2 (concentration of both crystal proteins) , although growth of these larvae was severely stunted. Purified B.t. thompsoni crystals were also tested for toxicity to the dipteran, Aedes aegypti, and the coleopteran, Leptinotarsa decemlineata (Colorado potato beetle) , but no toxicity was observed. Table 1: Assay for toxicity of B.t. thompsoni crystals and inclusions purified from recombinant E. coli strains. Expressed gene (s) LC 50 for 34-kDa Organism or clone (kDa) M. sexta concn B.t. thompsoni 40, 34 0.40 0.25 pKB102 40, 34 0.40 0.25 PKB107 40 >3.0 pKB109 34 0.25 0.25 pKB200 40 >3.0 pKB201 34 0.25 0.25 pKB202 40,34 0.98 0.25 The molecular mass in kilodaltons of the protein which the gene encodes. b LC 50 values (in micrograms per square centimeter ± 50%) are based on total concentration of expressed polypeptide(s) . Protein concentrations were estimated as described above. c Estimated protein concentration (in micrograms per square centimeter ± 50%) of the 34-kDa polypeptide at the LC 50 values of the various clones. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: Brown, Kit L. Whiteley, Helen R. (ϋ) TITLE OF INVENTION: CRYSTAL PROTEINS OF BACILLUS THURINGIENSIS, GENES ENCODING THEM, AND HOSTS EXPRESSING THEM (iii) NUMBER OF SEQUENCES: 9 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Wegner, Cantor, Mueller & Player (B) STREET: 1233 20th Street, N.W. (C) CITY: Washington (D) STATE: D.C. (F) ZIP: 20036-8218 (V) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.25 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (viϋ) ATTORNEY/AGENT INFORMATION: (A) NAME: Cantor, Herbert I. (B) REGISTRATION NUMBER: 24,392 (C) REFERENCE/DOCKET NUMBER: P-9575-23207 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: 202-887-0400 (B) TELEFAX: 202-835-0605 (C) TELEX: 440706 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: YES (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: thompsoni (ix) FEATURE: (A) NAME/KEY: modified_base (B) LOCATION: 20..21 (C) IDENTIFICATION METHOD: experimental (D) OTHER INFORMATION: /evidence= EXPERIMENTAL /mod_base * = i (ix) FEATURE: (A) NAME/KEY: modified_base (B) LOCATION: 22..23 (C) IDENTIFICATION METHOD: experimental (D) OTHER INFORMATION: /evidence= EXPERIMENTAL /mod_base= i (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: ATGAAYTTCA ACAAYATYAC GGAACTTYAA GGACGT 36 ( 2 ) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: thompsoni (ix) FEATURE: (A) NAME/KEY: modified_base (B) LOCATION: 14..15 (C) IDENTIFICATION METHOD: experimental (D) OTHER INFORMATION: /evidence= EXPERIMENTAL /mod_base= i (ix) FEATURE: (A) NAME/KEY: modified_base (B) LOCATION: 22..23 (C) IDENTIFICATION METHOD: experimental (D) OTHER INFORMATION: /evidence= EXPERIMENTAL /mod_base= i (ix) FEATURE: (A) NAME/KEY: modified_base (B) LOCATION: 24..25 (C) IDENTIFICATION METHOD: experimental (D) OTHER INFORMATION: /evidence= EXPERIMENTAL /mod_base= i (ix) FEATURE: (A) NAME/KEY: modified_base (B) LOCATION: 26..27 (C) IDENTIFICATION METHOD: experimental (D) OTHER INFORMATION: /evidence= EXPERIMENTAL /mod_base= i (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: ATGAATGAYA TWGCCARGAT GCGCMGGC 28 (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: thompsoni (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: GAGGGCCCAA TAAGGTGTCA GCT 23 (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: thompsoni (Xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: GCGTCGACTA TCATTCCATT ACAC 24 (2) INFORMATION FOR SEQ ID NO:5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: thompsoni ( i) SEQUENCE DESCRIPTION: SEQ ID NO:5: CTCCCGGGTG TAATGGAATG ATA 23 (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: thompsoni (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: GCTCTAGATC TTCACAATCC GGA 23 (2) INFORMATION FOR SEQ ID NO:7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2259 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (Vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: thompsoni (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: CCAATAAGGT GTCAGCTGAA TCTAAATTCG AAAGGAGAAT AAAAATGAAT TTTAACAATA 60 TCACAGGAAA TTTTAAAGAT GTCACAGAAC TATTTACAGA TTACGCTAAT CAATGGAGTC 120 GGCAAAATGG GGGTGGTAAG CCTGAAATTT CTCTTATAGT ACCAGGGTAT GAGGCTTATG 180 CTGTGACTAG TTCTGATGAT AGAACTATCT ATCATCATCC AAAGAAAAAG AAACGAGAAA 240 AATCGAGATC ACATCATGGT TGCTCAAGCG AGAACCAGGA ACGTATATAT GAAGATACGT 300 ATGAGACTAA TCTATCTTTC AATCATGATC CTAATTTAAT GGAAGAATGC GAAAAGGAAA 360 TTGAACTTGC AACTGAGACG TATGAAAATG CCAGTTGTCA TGAAAAGAAA ATAAAGATAC 420 AAATCGGTGG AAATGTAGAA AATTATGGTG AGTGGTTCGT TTACGAAGGG GCAACTTTAT 480 CAGGAAAAGA CCTTCTATCC ATTGATGTAT TTGGACATGA ACCAGTAGAC ATTGATCAAG 540 TCCCTGTTTC ATTGCATCCA GGAGAAATAG AAGTATTAAA GCGACCATTG GAAGTTGACA 600 CATATCGCTC TTATAAGATT CGCCCTCGTT CTAAGGTCAC TGCGACTTTG AAAGTAAAAC 660 AAAAACATTT TAAACAGTGC TTTGATGTGG AAACAGATGT ATCTGGTTAT GTTGCAATTA 720 TACAAAAACA AAAAGATTGT GATGTACAGA CATCATTTCA CCATGTTGCC GCTATTTTAC 780 AACGGTATTA CAGTCCCTTT ATTCGTATCA ATGGAGATGA AGTAACTTTA CTGTGTAAAG 840 GAGTATTTAA AGGGGTTAAG ATTACGGATA TATATATTCA TATCCAGATA GAAAGTTTAG 900 ATATTCCTGG ATTGATTGAA GAGTATAACA TTTATGATGT GAATCAACGA AATATAGGTG 960 TAATGGAATG ATAGTACAAA ACTCATAAAT TAGATTGATG AGAATCTGAT TTATATTTTA 1020 AAGGAGGAAT TTATAATGGC AATTATGAAT GATATTGCAC AAGATGCAGC AAGAGCTTGG 1080 GATATAATAG CAGGGCCATT TATACGACCG GGAACAACTC CTACCAATCG ACAATTATTT 1140 AATTATCAAA TTGGAAATAT AGAGGTTGAA CCTGGAAATC TTAATTTTTC AGTCGTCCCT 1200 GAACTAGACT TTAGTGTCTC TCAAGACCTT TTCAACAATA CAAGTGTGCA GCAAAGTCAA 1260 ACAGCATCAT TTAACGAATC AAGAACGGAA ACGACTTCAA CGGCCGTTAC TCATGGCGTA 1320 AAATCTGGGG TTACCGTTTC TGCTTCAGCA AAATTTAATG CCAAAATATT AGTAAAATCC 1380 ATTGAGCAAA CTATTACAAC AACGGTTTCT ACAGAATATA ATTTTAGTAG TACTACAACT 1440 AGAACAAATA CTGTAACAAG GGGATGGTCA ATTGCTCAGC CTGTATTAGT TCCTCCTCAT 1500 AGTAGAGTAA CAGCAACATT GCAAATTTAT AAAGGGGATT TTACAGTGCC CGTTCTATTA 1560 TCACTTAGAG TTTATGGTCA AACAGGAACA CTTGCAGGGA ATCCTAGTTT TCCTTCTTTA 1620 TATGCAGCCA CATATGAAAA CACACTTTTG GGAAGAATTA GAGAGCATAT TGCTCCACCT 1680 GCTCTTTTCA GAGCCTCCAA CGCATACATT TCGAATGGCG TTCAGGCAAT TTGGAGAGGA 1740 ACAGCAACGA CGAGAGTTTC GCAAGGTCTG TATTCCGTTG TAAGAATCGA TGAAAGACCT 1800 TTAGCAGGTT ATTCAGGAGA AACAAGAACG TATTATTTAC CAGTGACACT TTCAAATTCA 1860 AGTCAAATCC TTACACCTGG TTCTTTAGGA AGTGAGATTC CAATTATCAA TCCAGTTCCG 1920 AATGCATCTT GTAAAAAGGA AAACTCGCCT ATTATCATTC ATCATGATCG AGAGAAGCAT 1980 CGTGAACGCG ATTATGATAA AGAGCATATT TGTCATGATC AAGCTGAGAA GTATGAACGC 2040 GATTATGATA AAGAATAACT AATTATGTAA GAGATTTGTA AACAAGAGAA ATAGCATTTT 2100 ACTATTTCTC TTGTTTTTAA TCTATATATA GAATGGTAGA CGCTCTTTAA ATTAAATGTA 2160 AAAAAAGGGG GCTAAGATTA TAATGAAATC AAATCCAAAA CAATATATAG CTAATTATTT 2220 TACTTCTTTT TCATGTATTG GTCCGGATTG TGAAGATCA 2259 (2) INFORMATION FOR SEQ ID NO:8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 340 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (Vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: thompsoni (Xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: Met Ala lie Met Asn Asp lie Ala Gin Asp Ala Ala Arg Ala Trp 1 5 10 15 Asp lie lie Ala Gly Pro Phe lie Arg Pro Gly Thr Thr Pro Thr Asn 20 25 30 Arg Gin Leu Phe Asn Tyr Gin lie Gly Asn lie Glu Val Glu Pro Gly 35 40 45 Asn Leu Asn Phe Ser Val Val Pro Glu Leu Asp Phe Ser Val Ser Gin 50 55 60 Asp Leu Phe Asn Asn Thr Ser Val Gin Gin Ser Gin Thr Ala Ser Phe 65 70 75 Asn Glu Ser Arg Thr Glu Thr Thr Ser Thr Ala Val Thr His Gly Val 80 85 90 95 Lys Ser Gly Val Thr Val Ser Ala Ser Ala Lys Phe Asn Ala Lys lie 100 105 110 Leu Val Lys Ser lie Glu Gin Thr lie Thr Thr Thr Val Ser Thr Glu 115 120 125 Tyr Asn Phe Ser Ser Thr Thr Thr Arg Thr Asn Thr Val Thr Arg Gly 130 135 140 Trp Ser lie Ala Gin Pro Val Leu Val Pro Pro His Ser Arg Val Thr 145 150 155 Ala Thr Leu Gin lie Tyr Lys Gly Asp Phe Thr Val Pro Val Leu Leu 160 165 170 175 Ser Leu Arg Val Tyr Gly Gin Thr Gly Thr Leu Ala Gly Asn Pro Ser 180 185 190 Phe Pro Ser Leu Tyr Ala Ala Thr Tyr Glu Asn Thr Leu Leu Gly Arg 195 200 205 lie Arg Glu His lie Ala Pro Pro Ala Leu Phe Arg Ala Ser Asn Ala 210 215 220 Tyr lie Ser Asn Gly Val Gin Ala lie Trp Arg Gly Thr Ala Thr Thr 225 230 235 Arg Val Ser Gin Gly Leu Tyr Ser Val Val Arg lie Asp Glu Arg Pro 240 245 250 255 Leu Ala Gly Tyr Ser Gly Glu Thr Arg Thr Tyr Tyr Leu Pro Val Thr 260 265 270 Leu Ser Asn Ser Ser Gin lie Leu Thr Pro Gly Ser Leu Gly Ser Glu 275 280 285 lie Pro lie lie Asn Pro Val Pro Asn Ala Ser Cys Lys Lys Glu Asn 290 295 300 Ser Pro lie lie lie His His Asp Arg Glu Lys His Arg Glu Arg Asp 305 310 315 Tyr Asp Lys Glu His lie Cys His Asp Gin Ala Glu Lys Tyr Glu Arg 320 325 330 335 Asp Tyr Asp Lys Glu 340 (2) INFORMATION FOR SEQ ID NO:9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 308 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: thompsoni (Xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: Met Asn Phe Asn Asn lie Thr Gly Asn Phe Lys Asp Val Thr Glu 1 5 10 15 Leu Phe Thr Asp Tyr Ala Asn Gin Trp Ser Arg Gin Asn Gly Gly Gly 20 25 30 Lys Pro Glu lie Ser Leu lie Val Pro Gly Tyr Glu Ala Tyr Ala Val 35 40 45 Thr Ser Ser Asp Asp Arg Thr lie Tyr His His Pro Lys Lys Lys Lys 50 55 60 Arg Glu Lys Ser Arg Ser His His Gly Cys Ser Ser Glu Asn Gin Glu 65 70 75 Arg lie Tyr Glu Asp Thr Tyr Glu Thr Asn Leu Ser Phe Asn His Asp 80 85 90 95 Pro Asn Leu Met Glu Glu Cys Glu Lys Glu lie Glu Leu Ala Thr Glu 100 105 110 Thr Tyr Glu Asn Ala Ser Cys His Glu Lys Lys lie Lys lie Gin lie 115 120 125 Gly Gly Asn Val Glu Asn Tyr Gly Glu Trp Phe Val Tyr Glu Gly Ala 130 135 140 Thr Leu Ser Gly Lys Asp Leu Leu Ser lie Asp Val Phe Gly His Glu 145 150 155 Pro Val Asp lie Asp Gin Val Pro Val Ser Leu His Pro Gly Glu lie 160 165 170 175 Glu Val Leu Lys Arg Pro Leu Glu Val Asp Thr Tyr Arg Ser Tyr Lys 180 185 190 lie Arg Pro Arg Ser Lys Val Thr Ala Thr Leu Lys Val Lys Gin Lys 195 200 205 His Phe Lys Gin Cys Phe Asp Val Glu Thr Asp Val Ser Gly Tyr Val 210 215 220 Ala lie lie Gin Lys Gin Lys Asp Cys Asp Val Gin Thr Ser Phe His 225 230 235 His Val Ala Ala lie Leu Gin .Arg Tyr Tyr Ser Pro Phe lie Arg lie 240 245 250 255 Asn Gly Asp Glu Val Thr Leu Leu Cys Lys Gly Val Phe Lys Gly Val 260 265 270 Lys lie Thr Asp lie Tyr lie His lie Gin lie Glu Ser Leu Asp lie 275 280 285 Pro Gly Leu lie Glu Glu Tyr Asn lie Tyr Asp Val Asn Gin Arg Asn 290 295 300 He Gly Val Met Glu 305

Claims: We claim: 1. An isolated crystalline insect toxin from Bacillus thuringiensis, wherein said crystalline insect toxin is characterized by a cuboidal three-dimensional structure and comprises two polypeptides having electrophoretic mobilities of around 34 and 40 kDa. 2. An isolated crystalline insect toxin according to claim 1, wherein said crystalline insect toxin is further characterized in that the two polypeptides have the following amino acid sequences: Met Ala He Met Asn Asp He Ala Gin Asp Ala Ala Arg Ala Trp 1 5 10 15 Asp He He Ala Gly Pro Phe He Arg Pro Gly Thr Thr Pro Thr Asn 20 25 30 Arg Gin Leu Phe Asn Tyr Gin He Gly Asn He Glu Val Glu Pro Gly 35 40 45 Asn Leu Asn Phe Ser Val Val Pro Glu Leu Asp Phe Ser Val Ser Gin 50 55 60 Asp Leu Phe Asn Asn Thr Ser Val Gin Gin Ser Gin Thr Ala Ser Phe 65 70 75 Asn Glu Ser Arg Thr Glu Thr Thr Ser Thr Ala Val Thr His Gly Val 80 85 90 95 Lys Ser Gly Val Thr Val Ser Ala Ser Ala Lys Phe Asn Ala Lys He 100 105 110 Leu Val Lys Ser He Glu Gin Thr He Thr Thr Thr Val Ser Thr Glu 115 120 125 Tyr Asn Phe Ser Ser Thr Thr Thr Arg Thr Asn Thr Val Thr Arg Gly 130 135 140 Trp Ser He Ala Gin Pro Val Leu Val Pro Pro His Ser Arg Val Thr 145 150 155 Ala Thr Leu Gin He Tyr Lys Gly Asp Phe Thr Val Pro Val Leu Leu 160 165 170 175 Ser Leu Arg Val Tyr Gly Gin Thr Gly Thr Leu Ala Gly Asn Pro Ser 180 185 190 Phe Pro Ser Leu Tyr Ala Ala Thr Tyr Glu Asn Thr Leu Leu Gly Arg 195 200 205 He Arg Glu His He Ala Pro Pro Ala Leu Phe Arg Ala Ser Asn Ala 210 215 220 Tyr He Ser Asn Gly Val Gin Ala He Trp Arg Gly Thr Ala Thr Thr 225 230 235 Arg Val Ser Gin Gly Leu Tyr Ser Val Val Arg He Asp Glu Arg Pro 240 245 250 255 Leu Ala Gly Tyr Ser Gly Glu Thr Arg Thr Tyr Tyr Leu Pro Val Thr 260 265 270 Leu Ser Asn Ser Ser Gin He Leu Thr Pro Gly Ser Leu Gly Ser Glu 275 280 285 -> He Pro He He Asn Pro Val Pro Asn Ala Ser Cys Lys Lys Glu Asn 290 295 300 0 Ser Pro He He He His His Asp Arg Glu Lys His Arg Glu Arg Asp 305 310 315 Tyr Asp Lys Glu His He Cys His Asp Gin Ala Glu Lys Tyr Glu Arg 320 325 330 335 Asp Tyr Asp Lys Glu 340 and Met Asn Phe Asn Asn He Thr Gly Asn Phe Lys Asp Val Thr Glu 1 5 10 15 Leu Phe Thr Asp Tyr Ala Asn Gin Trp Ser Arg Gin Asn Gly Gly Gly 20 25 30 Lys Pro Glu He Ser Leu He Val Pro Gly Tyr Glu Ala Tyr Ala Val 35 40 45 Thr Ser Ser Asp Asp Arg Thr He Tyr His His Pro Lys Lys Lys Lys 50 55 60 Arg Glu Lys Ser Arg Ser His His Gly Cys Ser Ser Glu Asn Gin Glu 65 70 75 Arg He Tyr Glu Asp Thr Tyr Glu Thr Asn Leu Ser Phe Asn His Asp 80 85 90 95 Pro Asn Leu Met Glu Glu Cys Glu Lys Glu He Glu Leu Ala Thr Glu 100 105 110 Thr Tyr Glu Asn Ala Ser Cys His Glu Lys Lys He Lys He Gin He 115 120 125 Gly Gly Asn Val Glu Asn Tyr Gly Glu Trp Phe Val Tyr Glu Gly Ala 130 135 140 Thr Leu Ser Gly Lys Asp Leu Leu Ser He Asp Val Phe Gly His Glu 145 150 155 Pro Val Asp He Asp Gin Val Pro Val Ser Leu His Pro Gly Glu He 160 165 170 175 Glu Val Leu Lys Arg Pro Leu Glu Val Asp Thr Tyr Arg Ser Tyr Lys 180 185 190 He Arg Pro Arg Ser Lys Val Thr Ala Thr Leu Lys Val Lys Gin Lys 195 200 205 His Phe Lys Gin Cys Phe Asp Val Glu Thr Asp Val Ser Gly Tyr Val 210 215 220 Ala He He Gin Lys Gin Lys Asp Cys Asp Val Gin Thr Ser Phe His 225 230 235 His Val Ala Ala He Leu Gin Arg Tyr Tyr Ser Pro Phe He Arg He 240 245 250 255 Asn Gly Asp Glu Val Thr Leu Leu Cys Lys Gly Val Phe Lys Gly Val D 260 265 270 Lys He Thr Asp He Tyr He His He Gin He Glu Ser Leu Asp He 0 275 280 285 Pro Gly Leu He Glu Glu Tyr Asn He Tyr Asp Val Asn Gin Arg Asn 290 295 300 He Gly Val Met Glu. 305 3. A purified insecticidal polypeptide having an electrophoretic mobility of around 34 kDa which is produced by Bacillus thuringiensis. 4. A purified insecticidal polypeptide according to claim 3, wherein the insecticidal polypeptide is encoded by a gene located on an 8.4 kb EcoRI fragment of a 100 MDa plasmid found in Bacillus thuringiensis subspecies thompsoni. 5. A purified insecticidal polypeptide according to claim 4, wherein the insecticidal polypeptide has the following amino acid sequence: Met Ala He Met Asn Asp He Ala Gin Asp Ala Ala Arg Ala Trp 1 5 10 15 Asp He He Ala Gly Pro Phe He Arg Pro Gly Thr Thr Pro Thr Asn 20 25 30 Arg Gin Leu Phe Asn Tyr Gin He Gly Asn He Glu Val Glu Pro Gly 35 40 45 Asn Leu Asn Phe Ser Val Val Pro Glu Leu Asp Phe Ser Val Ser Gin 50 55 60 Asp Leu Phe Asn Asn Thr Ser Val Gin Gin Ser Gin Thr Ala Ser Phe 65 70 75 Asn Glu Ser Arg Thr Glu Thr Thr Ser Thr Ala Val Thr His Gly Val 80 85 90 95 Lys Ser Gly Val Thr Val Ser Ala Ser Ala Lys Phe Asn Ala Lys He 100 105 110 Leu Val Lys Ser He Glu Gin Thr He Thr Thr Thr Val Ser Thr Glu 115 120 125 Tyr Asn Phe Ser Ser Thr Thr Thr Arg Thr Asn Thr Val Thr Arg Gly 130 135 140 Trp Ser He Ala Gin Pro Val Leu Val Pro Pro His Ser Arg Val Thr 145 150 155 Ala Thr Leu Gin He Tyr Lys Gly Asp Phe Thr Val Pro Val Leu Leu 160 165 170 175 Ser Leu Arg Val Tyr Gly Gin Thr Gly Thr Leu Ala Gly Asn Pro Ser 180 185 190 Phe Pro Ser Leu Tyr Ala Ala Thr Tyr Glu Asn Thr Leu Leu Gly Arg 195 200 205 He Arg Glu His He Ala Pro Pro Ala Leu Phe Arg Ala Ser Asn Ala 210 215 220 Tyr lie Ser Asn Gly Val Gin Ala lie Trp Arg Gly Thr Ala Thr Thr 225 230 235 Arg Val Ser Gin Gly Leu Tyr Ser Val Val Arg He Asp Glu Arg Pro 240 245 250 255 Leu Ala Gly Tyr Ser Gly Glu Thr Arg Thr Tyr Tyr Leu Pro Val Thr 260 265 270 Leu Ser Asn Ser Ser Gin He Leu Thr Pro Gly Ser Leu Gly Ser Glu 275 280 285 He Pro He He Asn Pro Val Pro Asn Ala Ser Cys Lys Lys Glu Asn 290 295 300 Ser Pro He He He His His Asp Arg Glu Lys His Arg Glu Arg Asp 305 310 315 Tyr Asp Lys Glu His He Cys His Asp Gin Ala Glu Lys Tyr Glu Arg 320 325 330 335 Asp Tyr Asp Lys Glu, 340 or a substantially homologous sequence having insecticidal activity. 6 . A purified insecticidal polypeptide having the amino acid sequence: Met Ala He Met Asn Asp He Ala Gin Asp Ala Ala Arg Ala Trp 1 5 10 15 Asp He He Ala Gly Pro Phe He Arg Pro Gly Thr Thr Pro Thr Asn 20 25 30 Arg Gin Leu Phe Asn Tyr Gin He Gly Asn He Glu Val Glu Pro Gly 35 40 45 Asn Leu Asn Phe Ser Val Val Pro Glu Leu Asp Phe Ser Val Ser Gin 50 55 60 Asp Leu Phe Asn Asn Thr Ser Val Gin Gin Ser Gin Thr Ala Ser Phe 65 70 75 Asn Glu Ser Arg Thr Glu Thr Thr Ser Thr Ala Val Thr His Gly Val 80 85 90 95 Lys Ser Gly Val Thr Val Ser Ala Ser Ala Lys Phe Asn Ala Lys He 100 105 110 Leu Val Lys Ser He Glu Gin Thr He Thr Thr Thr Val Ser Thr Glu 115 120 125 Tyr Asn Phe Ser Ser Thr Thr Thr Arg Thr Asn Thr Val Thr Arg Gly 130 135 140 Trp Ser He Ala Gin Pro Val Leu Val Pro Pro His Ser Arg Val Thr 145 150 155 Ala Thr Leu Gin lie Tyr Lys Gly Asp Phe Thr Val Pro Val Leu Leu 160 165 170 175 Ser Leu Arg Val Tyr Gly Gin Thr Gly Thr Leu Ala Gly Asn Pro Ser 180 185 190 Phe Pro Ser Leu Tyr Ala Ala Thr Tyr Glu Asn Thr Leu Leu Gly Arg 195 200 205 He Arg Glu His He Ala Pro Pro Ala Leu Phe Arg Ala Ser Asn Ala 210 215 220 Tyr He Ser Asn Gly Val Gin Ala He Trp Arg Gly Thr Ala Thr Thr 225 230 235 Arg Val Ser Gin Gly Leu Tyr Ser Val Val Arg He Asp Glu Arg Pro 240 245 250 255 Leu Ala Glv Tyr Ser Gly Glu Thr Arg Thr Tyr Tyr Leu Pro Val Thr 260 265 270 Leu Ser Asn Ser Ser Gin He Leu Thr Pro Gly Ser Leu Gly Ser Glu 275 280 285 He Pro He He Asn Pro Val Pro Asn Ala Ser Cys Lys Lys Glu Asn 290 295 300 Ser Pro He He He His His Asp Arg Glu Lys His Arg Glu Arg Asp 305 310 315 Tyr Asp Lys Glu His He Cys His Asp Gin Ala Glu Lys Tyr Glu Arg 320 325 330 335 Aso Tvr ASP Lvs Glu. 340 7. An isolated DNA fragment having the nucleotide sequence 1 CCAATAAGGTGTCAGCTGAATCTAAATTCGAAAGGAGAATAAAAATGAATTTTAACAATATCAC 101 AGGAAATTTTAAAGATGTCACAGAACTATTTACAGATTACGCTAATCAATGGAGTCGGCAAAA TGGGGGTGGTAAGCCTGAAATTTCTCTTATAGTACCAGGGTATGAGGCTTATGCTGTGACTAG 201 TTCTGATGATAGAACTATCTATCATCATCCAAAGAAAAAGAAACGAGAAAAATCGAGATCACA 301 TCATGGTTGCTCAAGCGAGAACCAGGAACGTATATATGAAGATACGTATGAGACTAATCTATC TTTCAATCATGATCCTAATTTAATGGAAGAATGCGAAAAGGAAATTGAACTTGCAACTGAGAC 401 GTATGAAAATGCCAGTTGTCATGAAAAGAAAATAAAGATACAAATCGGTGGAAATGTAGAAAA 501 TTATGGTGAGTGGTTCGTTTACGAAGGGGCAACTTTATCAGGAAAAGACCTTCTATCCATTGA TGTATTTGGACATGAACCAGTAGACATTGATCAAGTCCCTGTTTCATTGCATCCAGGAGAAAT 601 AGAAGTATTAAAGCGACCATTGGAAGTTGACACATATCGCTCTTATAAGATTCGCCCTCGTTC TAAGGTCACTGCGACTTTGAAAGTAAAACAAAAACATTTTAAACAGTGCTTTGATGTGGAAAC 701 AGATGTATCTGGTTATGTTGCAATTATACAAAAACAAAAAGATTGTGATGTACAGACATCATTTC 801 --- ACCATGTTGCCGCTATTTTACAACGGTATTACAGTCCCTTTATTCGTATCAATGGAGATGAAGTA ACTTTACTGTGTAAAGGAGTATTTAAAGGGGTTAAGATTACGGATATATATATTCATATCCAGATA 901 GAAAGTTTAGATATTCCTGGATTGATTGAAGAGTATAACATTTATGATGTGAATCAACGAAATATA 1001 GGTGTAATGGAATGATAGTACAAAACTCATAAATTAGATTGATGAGAATCTGATTTATATTTTAAA GGAGGAATTTATAATGGCAATTATGAATGATATTGCACAAGATGCAGCAAGAGCTTGGGATATAAT 1101 AGCAGGGCCATTTATACGACCGGGAACAACTCCTACCAATCGACAATTATTTAATTATCAAATTG 1201 GAAATATAGAGGTTGAACCTGGAAATCTTAATTTTTCAGTCGTCCCTGAACTAGACTTTAGTGTC TCTCAAGACCTTTTCAACAATACAAGTGTGCAGCAAAGTCAAACAGCATCATTTAACGAATCAAG 1301 AACGGAAACGACTTCAACGGCCGTTACTCATGGCGTAAAATCTGGGGTTACCGTTTCTGCTTCAG 1401 CAAAATTTAATGCCAAAATATTAGTAAAATCCATTGAGCAAACTATTACAACAACGGTTTCTACA GAATATAATTTTAGTAGTACTACAACTAGAACAAATACTGTAACAAGGGGATGGTCAATTGCTCA 1501 GCCTGTATTAGTTCCTCCTCATAGTAGAGTAACAGCAACATTGCAAATTTATAAAGGGGATTTTA 1601 CAGTGCCCGTTCTATTATCACTTAGAGTTTATGGTCAAACAGGAACACTTGCAGGGAATCCTAGT TTTCCTTCTTTATATGCAGCCACATATGAAAACACACTTTTGGGAAGAATTAGAGAGCATATTGC 1701 TCCACCTGCTCTTTTCAGAGCCTCCAACGCATACATTTCGAATGGCGTTCAGGCAATTTGGAGAG 1801 GAACAGCAACGACGAGAGTTTCGCAAGGTCTGTATTCCGTTGTAAGAATCGATGAAAGACCTTTA GCAGGTTATTCAGGAGAAACAAGAACGTATTATTTACCAGTGACACTTTCAAATTCAAGTCAAAT 1901 CCTTACACCTGGTTCTTTAGGAAGTGAGATTCCAATTATCAATCCAGTTCCGAATGCATCTTGTA AAAAGGAAAACTCGCCTATTATCATTCATCATGATCGAGAGAAGCATCGTGAACGCGATTATGA 2001 TAAAGAGCATATTTGTCATGATCAAGCTGAGAAGTATGAACGCGATTATGATAAAGAATAACTAA 2101 TTATGTAAGAGATTTGTAAACAAGAGAAATAGCATTTTACTATTTCTCTTGTTTTTAATCTATAT ATAGAATGGTAGACGCTCTTTAAATTAAATGTAAAAAAAGGGGGCTAAGATTATAATGAAATCAA 2201 ATCCAAAACAATATATAGCTAATTATTTTACTTCTTTTTCATGTATTGGTCCGGATTGTGAAGAT CA, or an equivalent nucleotide sequence coding for the following two amino acid seouences: Met Ala He Met Asn Asp He Ala Gin Asp Ala Ala Arg Ala Trp 1 5 10 15 Asp He lie Ala Gly Pro Phe He Arg Pro Gly Thr Thr Pro Thr Asn 20 25 30 Arg Gin Leu Phe Asn Tyr Gin He Gly Asn He Glu Val Glu Pro Gly 35 40 45 Asn Leu Asn Phe Ser Val Val Pro Glu Leu Asp Phe Ser Val Ser Gin 50 55 60 Asp Leu Phe Asn Asn Thr Ser Val Gin Gin Ser Gin Thr Ala Ser Phe 65 70 75 Asn Glu Ser Arg Thr Glu Thr Thr Ser Thr Ala Val Thr His Gly Val 80 85 90 95 Lys Ser Gly Val Thr Val Ser Ala Ser Ala Lys Phe Asn Ala Lys He 100 105 110 Leu Val Lys Ser He Glu Gin Thr He Thr Thr Thr Val Ser Thr Glu 115 120 125 Tyr Asn .Phe Ser Ser Thr Thr Thr Arg Thr Asn Thr Val Thr Arg Gly 130 135 140 Trp Ser He Ala Gin Pro Val Leu Val Pro Pro His Ser Arg Val Thr 145 150 155 Ala Thr Leu Gin He Tyr Lys Gly Asp Phe Thr Val Pro Val Leu Leu 160 165 170 175 Ser Leu Arg Val Tyr Gly Gin Thr Gly Thr Leu Ala Gly Asn Pro Ser 180 185 190 Phe Pro Ser Leu Tyr Ala Ala Thr Tyr Glu Asn Thr Leu Leu Gly Arg 195 200 205 He Arg Glu His He Ala Pro Pro Ala Leu Phe Arg Ala Ser Asn Ala 210 215 220 Tyr He Ser Asn Gly Val Gin Ala He Trp Arg Gly Thr Ala Thr Thr 225 230 235 Arg Val Ser Gin Gly Leu Tyr Ser Val Val Arg He Asp Glu Arg Pro 240 245 250 255 Leu Ala Gly Tyr Ser Gly Glu Thr Arg Thr Tyr Tyr Leu Pro Val Thr 260 265 270 Leu Ser Asn Ser Ser Gin lie Leu Thr Pro Gly Ser Leu Gly Ser Glu 275 280 285 He Pro He He Asn Pro Val Pro Asn Ala Ser Cys Lys Lvε Glu Asn 290 295 300 « Ser Pro He He He His His Asp Arg Glu Lys His Arg Glu Arg Asp 305 310 315 Tyr Asp Lys Glu His He Cys His Asp Gin Ala Glu Lys Tyr Glu Arg 320 325 330 335 Asp Tyr Asp Lys Glu 340 and Met Asn Phe Asn Asn He Thr Gly Asn Phe Lys Asp Val Thr Glu 1 5 10 15 Leu Phe Thr Asp Tyr Ala Asn Gin Trp Ser Arg Gin Asn Gly Gly Gly 20 25 30 Lys Pro Glu He Ser Leu He Val Pro Gly Tyr Glu Ala Tyr Ala Val 35 40 45 Thr Ser Ser Asp Asp Arg Thr He Tyr His His Pro Lys Lys Lys Lys 50 55 60 Arg Glu Lys Ser Arg Ser His His Gly Cys Ser Ser Glu Asn Gin Glu 65 70 75 Arg He Tyr Glu Asp Thr Tyr Glu Thr Asn Leu Ser Phe Asn His Asp 80 85 90 95 Pro Asn Leu Met Glu Glu cys Glu Lys Glu He Glu Leu Ala Thr Glu 100 105 110 Thr Tyr Glu Asn Ala Ser Cys His Glu Lys Lys He Lys He Gin He 115 120 125 Gly Gly Asn Val Glu Asn Tyr Gly Glu Trp Phe Val Tyr Glu Gly Ala 130 135 140 Thr Leu Ser Gly Lys Asp Leu Leu Ser He Asp Val Phe Gly His Glu 145 150 155 Pro Val Asp He Asp Gin Val Pro Val Ser Leu His Pro Gly Glu He 160 165 170 175 Glu Val Leu Lys Arg Pro Leu Glu Val Asp Thr Tyr Arg Ser Tyr Lys 180 185 190 He Arg Pro Arg Ser Lys Val Thr Ala Thr Leu Lys Val Lys Gin Lys 195 200 205 His Phe Lys Gin Cys Phe Asp Val Glu Thr Asp Val Ser Gly Tyr Val 210 215 220 Ala He He Gin Lys Gin Lys Asp Cys Asp Val Gin Thr Ser Phe His 225 230 235 His Val Ala Ala He Leu Gin Arg Tyr Tyr Ser Pro Phe He Arg He 240 245 250 255 Asn Gly Asp Glu Val Thr Leu Leu Cys Lys Gly Val Phe Lys Gly Val 260 265 270 Lys He Thr Asp He Tyr He His He Gin He Glu Ser Leu Asp He 275 280 285 Pro Gly Leu He Glu Glu Tyr Asn He Tyr Asp Val Asn Gin Arg Asn 290 295 300 He Gly Val Met Glu. 305 8. An isolated DNA fragment having the nucleotide sequence GGAGGAATTTATAATGGCAATTATGAATGATATTGCACAAGATGCAGCAAGAGCTTGGGATATAAT 1101 AGCAGGGCCATTTATACGACCGGGAACAACTCCTACCAATCGACAATTATTTAATTATCAAATTG 1201 GAAATATAGAGGTTGAACCTGGAAATCTTAATTTTTCAGTCGTCCCTGAACTAGACTTTAGTGTC TCTCAAGACCTTTTCAACAATACAAGTGTGCAGCAAAGTCAAACAGCATCATTTAACGAATCAAG 1301 AACGGAAACGACTTCAACGGCCGTTACTCATGGCGTAAAATCTGGGGTTACCGTTTCTGCTTCAG 1401 CAAAATTTAATGCCAAAATATTAGTAAAATCCATTGAGCAAACTATTACAACAACGGTTTCTACA GAATATAATTTTAGTAGTACTACAACTAGAACAAATACTGTAACAAGGGGATGGTCAATTGCTCA 1501 GCCTGTATTAGTTCCTCCTCATAGTAGAGTAACAGCAACATTGCAAATTTATAAAGGGGATTTTA 1601 CAGTGCCCGTTCTATTATCACTTAGAGTTTATGGTCAAACAGGAACACTTGCAGGGAATCCTAGT TTTCCTTCTTTATATGCAGCCACATATGAAAACACACTTTTGGGAAGAATTAGAGAGCATATTGC 1701 TCCACCTGCTCTTTTCAGAGCCTCCAACGCATACATTTCGAATGGCGTTCAGGCAATTTGGAGAG 1801 GAACAGCAACGACGAGAGTTTCGCAAGGTCTGTATTCCGTTGTAAGAATCGATGAAAGACCTTTA GCAGGTTATTCAGGAGAAACAAGAACGTATTATTTACCAGTGACACTTTCAAATTCAAGTCAAAT 1901 CCTTACACCTGGTTCTTTAGGAAGTGAGATTCCAATTATCAATCCAGTTCCGAATGCATCTTGTA AAAAGGAAAACTCGCCTATTATCATTCATCATGATCGAGAGAAGCATCGTGAACGCGATTATGA 2001 TAAAGAGCATATTTGTCATGATCAAGCTGAGAAGTATGAACGCGATTATGATAAAGAATAACTAA 2101 TTATGTAAGAGATTTGTAAACAAGAGAAATAGCATTTTACTATTTCTCTTGTTTTTAATCTATAT ATAGAATGGTAGACGCTCTTTAAATTAAATGTAAAAAAAGGGGGCTAAGATTATAATGAAATCAA 2201 ATCCAAAACAATATATAGCTAATTATTTTACTTCTTTTTCATGTATTGGTCCGGATTGTGAAGAT CA, or an equivalent nucleotide sequence coding for the amino acid sequence Met Ala He Met Asn Asp He Ala Gin Asp Ala Ala Arg Ala Trp 1 5 10 15 Asp He He Ala Gly Pro Phe He Arg Pro Gly Thr Thr Pro Thr Asn 20 25 30 Arg Gin Leu Phe Asn Tyr Gin He Gly Asn He Glu Val Glu Pro Gly 35 40 45 Asn Leu Asn Phe Ser Val Val Pro Glu Leu Asp Phe Ser Val Ser Gin 50 55 60 Asp Leu Phe Asn Asn Thr Ser Val Gin Gin Ser Gin Thr Ala Ser Phe 65 70 75 Asn Glu Ser Arg Thr Glu Thr Thr Ser Thr Ala Val Thr His Gly Val 80 85 90 95 Lys Ser Gly Val Thr Val Ser Ala Ser Ala Lys Phe Asn Ala Lys He 100 105 110 Leu Val Lys Ser He Glu Gin Thr He Thr Thr Thr Val Ser Thr Glu 115 120 125 Tyr Asn Phe Ser Ser Thr Thr Thr Arg Thr Asn Thr Val Thr Arg Gly 130 135 140 Trp Ser He Ala Gin Pro Val Leu Val Pro Pro His Ser Arg Val Thr 145 150 155 Ala Thr Leu Gin He Tyr Lys Gly Asp Phe Thr Val Pro Val Leu Leu 160 165 170 175 Ser Leu Arg Val Tyr Gly Gin Thr Gly Thr Leu Ala Gly Asn Pro Ser 180 185 190 Phe Pro Ser Leu Tyr Ala Ala Thr Tyr Glu Asn Thr Leu Leu Gly Arg 195 200 205 He Arg Glu His He Ala Pro Pro Ala Leu Phe Arg Ala Ser Asn Ala 210 215 220 Tyr He Ser Asn Gly Val Gin Ala He Trp Arg Gly Thr Ala Thr Thr 225 230 235 Arg Val Ser Gin Gly Leu Tyr Ser Val Val Arg He Asp Glu Arg Pr 240 245 250 25 Leu Ala Gly Tyr Ser Gly Glu Thr Arg Thr Tyr Tyr Leu Pro Val Th 260 265 270 Leu Ser Asn Ser Ser Gin He Leu Thr Pro Gly Ser Leu Gly Ser Gl 275 280 285 He Pro He He Asn Pro Val Pro Asn Ala Ser Cys Lys Lys Glu As 290 295 300 Ser Pro He He He His His Asp Arg Glu Lys His Arg Glu Arg Asp 305 310 315 Tyr Asp Lys Glu His He Cys His Asp Gin Ala Glu Lys Tyr Glu Arg 320 325 330 335 Asp Tyr Asp Lys Glu. 340 9. A recombinant DNA expression vector comprising an isolated DNA fragment according to claim 8. 10. A recombinant DNA expression vector according to claim 9 which is pKB201. 11. A recombinant DNA expression vector according to claim 9 which is pKB109. 12. A recombinant DNA expression vector comprising an isolated DNA fragment according to claim 7. 13. A recombinant DNA expression vector according to claim 12 which is pKB202. 1 . A recombinant DNA expression vector according to claim 12 which is PKB102. 15. A host transformed by a recombinant DNA expression vector according to claim 9 or 12. 16. A transformed host according to claim 15, wherein the host is E. coli. 17. A transformed host according to claim 16, wherein the recombinant DNA expression vector is pKB201. 18. A transformed host according to claim 16, wherein the recombinant DNA expression vector is pKB202. 19. A transformed host according to claim 16, wherein the recombinant DNA expression vector is pKB102. 20. A transformed host according to claim 16, wherein the recombinant DNA expression vector is pKB109. 21. A DNA probe for a toxin-encoding operon of Bacillus thuringiensis having a nucleotide sequence selected from one of the following formulas: 5'-ATG AAY TTC AAC AAY ATY ACI GGI AAC TTY AAG GAC GT-3 • or 5 « -ATG AAT GAY ATW GCI CAR GAT GCI GCI MGI GC-3 ' , wherein I represents deoxyinosine, Y represents C or T, W represents T or A, R represents G or A, and M represents C or A. 22. A method for producing an insect toxin of Bacillus thuringiensis wherein said method comprises (a) transforming a suitable host with a recombinant DNA expression vector according to claims 9 or 12, (b) culturing said transformed host from step (a) in a suitable culture medium, and (c) harvesting from the culture of step (b) an essentially pure insect toxin. 23. A method according to claim 22, wherein in step (a) , the recombinant DNA expression vector is pKB201. 24. A method according to claim 22, wherein in step (a), the recombinant DNA expression vector is pKB202. 25. A method according to claim 22, wherein in step (a), the recombinant DNA expression vector is pKB109. 26. A method according to claim 22, wherein in step (a), the recombinant DNA expression vector is pKB102. 27. A method of using a host transformed by a recombinant DNA expression vector according to any one of claims 9-14 to produce an insect toxin of Bacillus thuringiensis comprising (a) culturing said transformed host in a suitable culture medium, and (b) harvesting from the culture of step (a) an essentially pure insect toxin.

Inventors: BROWN KIT L, WHITELEY HELEN R, BROWN, KIT, L., WHITELEY, HELEN, R. +DI
Applicants: WASHINGTON RES FOUND, WASHINGTON RESEARCH FOUNDATION
Application year: 1992
Main classification: C07K13
IPC codes: C07K14, C12N1, C12N15